The hidden innovation system behind drug repurposing 

Pharmaceutical innovation often follows a familiar model: companies invest heavily in drug development, patents protect the resulting products, and commercial returns help fund the next generation of medicines. 

Boehringer licenses PVT virus platform for cancer vaccines

Why it matters: The deal gives Boehringer access to a viral vector technology that could support off-the-shelf cancer vaccines, a different route from the personalised mRNA approaches that dominate much of today’s therapeutic cancer vaccine discussion.

🎥 Can non thermal plasma seed treatment move from lab curiosity to broadacre reality?

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Sylvarum] Using non-thermal plasma or high voltage …

New Tetra Pak Bioreactor Promises Lower Costs From Pilot to Full-Scale Fermentation

Tetra Pak has launched its first industrial bioreactor, the Tetra Pak® Bioreactor RF, seven months after acquiring Bioreactors.net, the Latvia-based fermentation equipment specialist. The vessel is designed for producers moving fermentation-derived ingredients from pilot testing into full industrial output, and is available in sizes ranging from 10 to 50,000 litres, according to the company.

Graph Therapeutics raises $5m to advance I&I pipeline

Why it matters: Graph is moving from platform development into proprietary drug discovery, a shift many TechBio companies are pursuing as they try to capture more value from AI-enabled biology.

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare disease portfolio beyond its anchor indication of cystic fibrosis (CF), by adding an approved treatment and a pipeline anchored by two Phase III candidates, all predicted to generate more than $5 billion in annual revenue.

Thailand Eyes Carbon-Fed Microbial Protein as New Export Frontier

Thailand’s Ministry of Commerce is exploring carbon capture and utilisation (CCU) technology as a route into the global alternative protein market, according to a report from The Nation Thailand. The ministry’s Trade Policy and Strategy Office (TPSO) has flagged what it calls “carbon protein” as a frontier industry that could serve both food security goals and the country’s decarbonisation targets.

农药标签商标填报/变更新规:严把时限、强化留痕、压实主体责任

世界农化网中文网报道:2026年7月6日,农业农村部农药检定所发布关于规范农药标签商标填报及变更工作的通知。以"严把时限、强化留痕、压实主体责任"为管理主线,对农药标签商标的填报一致性、变更程序及信息公示作出了系统性规范。

AI Reveals Hidden Brain Lesions in Multiple Sclerosis MRI

It has long been known that brain gray matter plays a key role in multiple sclerosis (MS) disease progression and cognitive impairment, but because magnetic resonance imaging (MRI) has only been able to detect lesions in white matter, neither clinicians nor researchers have had a way to detect or monitor gray matter (cortical) lesions. And while many new drugs developed in the past decade can slow disease progression significantly, they primarily work on reducing white matter lesions.

PI Industries将推出印度首款自主创制杀虫剂Pioxaniliprole,可触达市场预估超数十亿美元

世界农化网中文网报道:近日,PI Industries宣布即将在印度推出该国首款自主研发并获专利的杀虫剂Pioxaniliprole,公司同时将美国和拉美国家列为优先市场,待获得必要监管批准后引入该产品。